Taking your company public through an IPO is a crucial step, presenting a unique opportunity to benefit both your business and its investors. Explore the Nasdaq IPO Academy, a program tailored to ...
Join the Future of Digital Finance: Dadachain's platform launch on March 17 marks an expansion of blockchain applications in asset tokenization. Email: [email protected] ...
The U.S. IPO market seems to be cooling off this week, with no major listing planned. This week, Advanced Biomed ( ADVB) is ...
AI Assets filed for a 2 million share initial public offering, and said it applied to list on the Nasdaq Capital Market. The a British Virgin Islands business company, through its Singapore subsidiary ...
European block trades are off to their strongest start for the year since 2021, defying the tempered enthusiasm for initial ...
Following the rebound in the US dollar rates, MCX gold rate witnessed some selling pressure in the Opening Bell ...
Nukleus Office Solutions’ IPO opens on February 24, offering 13.54 lakh fresh equity shares at Rs 234 per share, with no OFS ...
Inc. ("BioAge") (NASDAQ:BIOA) on behalf of those who purchased stock pursuant and/or traceable to BioAge's registration statement for its initial public offering ("IPO") held on or about September 26, ...
IPO content provided by Renaissance Capital LLC, manager of the IPO-focused ETFs (tickers: IPO, IPOs).
2-Year U.S. Treasury Note Continuous Contract $103.020-0.039-0.04% 5-Year U.S. Treasury Note Continuous Contract $107.297-0.047-0.04% 10-Year U.S. Treasury Note Continuous Contract $110.500-0.016 ...
MBX plans to list on the Nasdaq under the symbol MBX. The recent flurry of IPOs adds to the sense that the environment for biotechs seeking to go public after a two-year lull, with a pick-up in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results